Screening for Klinefelter syndrome by invasive diagnostics, requiring amniocentesis or chorionic villus sampling, carries a high risk of miscarriage and fetal malformations. NIPT fetal DNA testing in maternal blood is a new, safe diagnostic method and an effective prenatal screening option for Klinefelter syndrome.